AF
ROIV icon

Advisornet Financial’s Roivant Sciences ROIV Stock Holding History

Advisornet Financial’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2K Buy
882
+844
+2,221% +$24.9K ﹤0.01% 1257
2026
Q1 		$1.05K Buy
38
+4
+12% +$103 ﹤0.01% 2002
2025
Q4 		$738 Hold
34
– – ﹤0.01% 2041
2025
Q3 		$514 Sell
34
-19
-36% -$235 ﹤0.01% 2072
2025
Q2 		$597 Buy
+53
New +$574 ﹤0.01% 2028
2025
Q1 		– Sell
-1,707
Closed -$20.2K – 2233
2024
Q4 		$20.2K Buy
+1,707
New +$20.2K ﹤0.01% 1134

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Advisornet Financial's ROIV Position: Q2 2026 in Review

Advisornet Financial increased its Roivant Sciences (ROIV) stake by 2,221% in Q2 2026, buying an estimated $24.9K and bringing the position to 882 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Advisornet Financial first reported a position in ROIV in Q4 2024 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Advisornet Financial held 882 shares of Roivant Sciences worth $31.2K as of Q2 2026.
  • Advisornet Financial bought 844 Roivant Sciences shares in Q2 2026, an estimated $24.9K.
  • Roivant Sciences made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1257 holding.
  • Advisornet Financial first reported a position in Roivant Sciences in Q4 2024 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.